B Acute Lymphoblastic Leukemia Associated With Down Syndrome

1

Review clinical trials related to B Acute Lymphoblastic Leukemia Associated With Down Syndrome. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

This study attempts to learn more about the health of persons with Down syndrome after treatment for acute leukemia. Children with Down syndrome are at increased risk for side effects during treatment for acute leukemia, but it is unclear of their risk for long-term effects of cancer treatment. By learning more about the factors that may contribute to chronic health conditions and long-term effects after treatment for leukemia in persons with Down syndrome, clinical practice guidelines for survivorship care can be developed to help improve their quality-of-life.

Participants needed: 330
Trial details
Age: 6-39Biological sex: AllType: ObservationalSponsor: Children's Oncology GroupUpdated: May 5, 2026Locations: 70
Eligibility criteria

Patients age >= 6 and < 40 years at the time of enrollment [+12]

Patients with history of hematopoietic stem cell transplant (HSCT) are excluded [+4]